[go: up one dir, main page]

WO2002032938A3 - Regulation of human pgc-1-like protein - Google Patents

Regulation of human pgc-1-like protein Download PDF

Info

Publication number
WO2002032938A3
WO2002032938A3 PCT/EP2001/011924 EP0111924W WO0232938A3 WO 2002032938 A3 WO2002032938 A3 WO 2002032938A3 EP 0111924 W EP0111924 W EP 0111924W WO 0232938 A3 WO0232938 A3 WO 0232938A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein
human pgc
regulation
reagents
pgc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/011924
Other languages
French (fr)
Other versions
WO2002032938A2 (en
Inventor
Timothy J Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to AU2002215956A priority Critical patent/AU2002215956A1/en
Publication of WO2002032938A2 publication Critical patent/WO2002032938A2/en
Publication of WO2002032938A3 publication Critical patent/WO2002032938A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Reagents which regulate human PGC-1-like protein and reagents which bind to human PGC-1-like gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cancer, obesity, cardiovascular disorders, diabetes, and COPD.
PCT/EP2001/011924 2000-10-17 2001-10-16 Regulation of human pgc-1-like protein Ceased WO2002032938A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002215956A AU2002215956A1 (en) 2000-10-17 2001-10-16 Regulation of human pgc-1-like protein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24084400P 2000-10-17 2000-10-17
US60/240,844 2000-10-17

Publications (2)

Publication Number Publication Date
WO2002032938A2 WO2002032938A2 (en) 2002-04-25
WO2002032938A3 true WO2002032938A3 (en) 2002-11-07

Family

ID=22908175

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/011924 Ceased WO2002032938A2 (en) 2000-10-17 2001-10-16 Regulation of human pgc-1-like protein

Country Status (2)

Country Link
AU (1) AU2002215956A1 (en)
WO (1) WO2002032938A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003042362A2 (en) 2001-11-09 2003-05-22 Dana-Farber Cancer Institute, Inc. PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
US7947652B2 (en) * 2004-09-03 2011-05-24 Dana-Farber Cancer Institute, Inc. Compositions and methods for modulating PGC-1α to treat huntington's disease
ES2397889B1 (en) 2011-03-25 2014-02-07 Lipotec, S.A. MODULATING PEPTIDES OF PGC-1 Alpha.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000032215A1 (en) * 1998-12-01 2000-06-08 Dana-Farber Cancer Institute PGC-1, A NOVEL BROWN FAT PPARη COACTIVATOR

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000032215A1 (en) * 1998-12-01 2000-06-08 Dana-Farber Cancer Institute PGC-1, A NOVEL BROWN FAT PPARη COACTIVATOR

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ESTERBAUER HARALD ET AL: "Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 62, no. 1, 15 November 1999 (1999-11-15), pages 98 - 102, XP002181538, ISSN: 0888-7543 *
LARROUY D ET AL: "CLONING AND MRNA TISSUE DISTRIBUTION OF HUMAN PPARGAMMA COACTIVATOR-1", INTERNATIONAL JOURNAL OF OBESITY, NEWMAN PUBLISHING, LONDON, GB, vol. 23, no. 12, December 1999 (1999-12-01), pages 1327 - 1332, XP001022168, ISSN: 0307-0565 *

Also Published As

Publication number Publication date
WO2002032938A2 (en) 2002-04-25
AU2002215956A1 (en) 2002-04-29

Similar Documents

Publication Publication Date Title
WO2002036754A3 (en) Nucleotide and polypeptide sequence of human lysosomal acid lipase
WO2002020731A3 (en) Regulation of human protein disulfide isomerase-like enzyme
WO2002061092A3 (en) Regulation of human lysyl oxidase
WO2002072824A3 (en) Human transient receptor potential channel protein.
WO2002032938A3 (en) Regulation of human pgc-1-like protein
WO2001077149A3 (en) Regulation of human cyslt2-like gpcr protein
WO2002062974A3 (en) Regulation of human elongase hselo1-like protein
WO2003004629A3 (en) Regulation of human citron rho/rac-interacting kinase-short kinase
WO2002055712A3 (en) Regulation of human alanine aminotransferase
WO2002036731A3 (en) Human lysosomal acid lipase
WO2002036613A3 (en) Regulation of human patched-like protein
WO2002062975A3 (en) Regulation of human elongase hselo1-like protein
WO2002081705A3 (en) Regulation of human gnat acetyltransferase-like protein
WO2002046403A3 (en) Regulation of human patched-like protein
WO2003052088A3 (en) Regulation of human sialyltransferase
WO2002033056A3 (en) Regulation of human serine-threonine protein kinase
WO2002026999A3 (en) Regulation of human adam-ts-like protein
WO2002099106A3 (en) Regulation of human secretin -type gpcr
WO2002081704A3 (en) Regulation of human protein kinase-like protein
WO2003016515A3 (en) Regulation of human glycerol-3-phosphate acyltransferase-like protein
WO2002024731A3 (en) Regulation of human fgd1-like protein
WO2002046402A3 (en) Regulation of human patched-like protein
WO2002055710A3 (en) Regulation of human purple acid phosphatase
WO2002072825A3 (en) Human mrp5-like protein
WO2003025174A3 (en) Regulation of human mrp1-like protein

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 10399140

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP